secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001493152-24-024277
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air appoints David Webster as Chief Commercial Officer effective July 8, 2024
--------------------------------------------------------------------------------

- David Webster appointed CCO, effective July 8, 2024, with over 20 years life sciences experience.
- Previously CEO of Body Vision Medical; led commercialization of Lung Vision system.
- Received inducement stock option for 125,000 shares, vesting over four years starting July 8, 2024.
- Company expects Webster to drive LungFit PH market share gains and strengthen commercial team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224024277/0001493152-24-024277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224024277/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer